Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Evolene is a French medical device company specializing in the design, manufacture, and distribution of high-quality surgical sutures and wound closure solutions. The company offers a comprehensive portfolio of products, including absorbable and non-absorbable sutures, surgical meshes for hernia repair, and hemostatic agents. Evolene serves various surgical specialties such as cardiovascular, ophthalmic, and general surgery, providing critical tools for operating rooms worldwide. Following its acquisition by Peters Surgical in 2015, and the subsequent acquisition of Peters Surgical by Medline in 2024, Evolene continues to operate as a key brand within the global healthcare supply chain. The company is recognized for its advanced manufacturing capabilities, including precision braiding and polymer extrusion, ensuring compliance with international medical standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Evolene.